Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-05-26 5:01 pm Purchase | 2021-05-17 | 13G | Aerpio Pharmaceuticals, Inc. ARPO | Point72 Asset Management, L.P. | 121,667 3.900% | 121,667 (New Position) | Filing History |
| 2021-05-18 4:32 pm Purchase | 2021-05-11 | 13G | F-star Therapeutics, Inc. FSTX | Point72 Asset Management, L.P. | 1,100,000 5.700% | 1,100,000 (New Position) | Filing History |
| 2021-05-18 4:30 pm Purchase | 2021-05-17 | 13G | Forte Biosciences, Inc. FBRX | Point72 Asset Management, L.P. | 27,842 5.200% | 27,842 (New Position) | Filing History |
| 2021-05-13 4:34 pm Purchase | 2021-05-04 | 13G | Global Blood Therapeutics, Inc. GBT | Point72 Asset Management, L.P. | 3,224,574 5.200% | 2,797,541 (+655.11%) | Filing History |
| 2021-04-01 4:57 pm Purchase | 2021-03-31 | 13G | Kindred Biosciences, Inc. KIN | Point72 Asset Management, L.P. | 3,858,103 8.700% | 3,858,103 (New Position) | Filing History |
| 2021-03-24 5:25 pm Purchase | 2021-03-23 | 13G | TRICIDA INC TCDAQ | Point72 Asset Management, L.P. | 2,525,538 5.000% | 2,525,538 (New Position) | Filing History |
| 2021-03-22 5:03 pm Purchase | 2021-03-12 | 13G | Curis, Inc. CRIS | Point72 Asset Management, L.P. | 266,997 5.800% | 266,997 (New Position) | Filing History |
| 2021-03-22 5:02 pm Purchase | 2021-03-16 | 13G | Prometheus Biosciences, Inc. RXDX | Point72 Asset Management, L.P. | 2,648,024 6.800% | 2,648,024 (New Position) | Filing History |
| 2021-03-02 5:04 pm Purchase | 2021-03-01 | 13G | Paya Holdings Inc. PAYA | Point72 Asset Management, L.P. | 6,459,793 5.500% | 6,459,793 (New Position) | Filing History |
| 2021-03-01 5:19 pm Purchase | 2021-02-17 | 13G | Mereo BioPharma Group plc MREO | Point72 Asset Management, L.P. | 6,899,669 6.400% | 6,899,669 (New Position) | Filing History |
| 2021-02-24 4:51 pm Purchase | 2021-02-23 | 13G | VPC Impact Acquisition Holdings VIH | Point72 Asset Management, L.P. | 1,159,546 5.600% | 1,159,546 (New Position) | Filing History |
| 2021-02-23 4:38 pm Purchase | 2021-02-22 | 13G | Chimerix, Inc. CMRX | Point72 Asset Management, L.P. | 3,835,470 5.000% | 3,669,906 (+2216.61%) | Filing History |
| 2021-02-16 3:34 pm Sale | 2020-12-31 | 13G | Vaccinex, Inc. VCNX | Point72 Asset Management, L.P. | 0 0.000% | -6,786 (Position Closed) | Filing History |
| 2021-02-16 3:33 pm Sale | 2020-12-31 | 13G | BGC Partners, Inc. BGCP | Point72 Asset Management, L.P. | 6,057,640 1.900% | -9,471,320 (-60.99%) | Filing History |
| 2021-02-16 3:32 pm Sale | 2020-12-31 | 13G | Calithera Biosciences, Inc. CALA | Point72 Asset Management, L.P. | 86,718 2.500% | -75,284 (-46.47%) | Filing History |
| 2021-02-16 3:31 pm Sale | 2020-12-31 | 13G | Chiasma, Inc. CHMA | Point72 Asset Management, L.P. | 1,266,112 2.200% | -1,235,217 (-49.38%) | Filing History |
| 2021-02-16 3:30 pm Sale | 2020-12-31 | 13G | IMMUNOMEDICS INC IMMU | Point72 Asset Management, L.P. | 0 0.000% | -10,954,266 (Position Closed) | Filing History |
| 2021-02-16 3:30 pm Sale | 2020-12-31 | 13G | Otonomy, Inc. OTIC | Point72 Asset Management, L.P. | 2,382,500 4.900% | -526,997 (-18.11%) | Filing |
| 2021-02-16 3:29 pm Sale | 2020-12-31 | 13G | Verastem, Inc. VSTM | Point72 Asset Management, L.P. | 550 0.100% | -458,946 (-99.88%) | Filing History |
| 2021-02-16 3:28 pm Purchase | 2020-12-31 | 13G | VYNE Therapeutics Inc. VYNE | Point72 Asset Management, L.P. | 1,447 0.100% | 1,447 (New Position) | Filing History |